Literature DB >> 5580942

Clindamycin levels in sputum in a patient with purulent chest disease due to cystic fibrosis.

J A Raeburn, J D Devine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5580942      PMCID: PMC2466915          DOI: 10.1136/pgmj.47.548.366

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.

Authors:  R F McGehee; C B Smith; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

2.  Clinical and bacteriological studies with clindamycin.

Authors:  A M Geddes; F A Bridgwater; D N Williams; J Oon; G J Grimshaw
Journal:  Br Med J       Date:  1970-06-20

3.  Chemotherapy of bronchitis.

Authors:  K Zinnemann; J Frazer
Journal:  Br Med J       Date:  1970-05-23
  3 in total
  5 in total

Review 1.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

2.  Effect of protein concentration and binding on antibiotic assays.

Authors:  L R Peterson; E A Schierl; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

Review 3.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 4.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

5.  Simple assay for clindamycin in the presence of aminoglycosides.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.